Press Releases
CPhI Middle East & Africa to take place in September 2021 under the patronage of Saudi Arabia’s Ministry of Health
Informa Markets, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, (CPhI MEA), has announced the 2020 edition of the...
News
Lantern Pharma Fox Chase Cancer Center Collaborate on Advancing the Development of LP-184 in Pancreatic Cancer
Lantern Pharma , a clinical-stage biopharma company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery & development and identify patients...
News
Serum Institute of India starts manufacturing Codagenix’s nasal COVID-19 vaccine
Serum Institute of India has started manufacturing COVID-19 vaccine candidate developed by Codagenix Inc, the US biotech firm said in a statement. Dubbed as...
News
Oxgene introduces TESSA technology for plasmid-free manufacturing system for Adeno-associated virus
Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch of its scalable, plasmid-free manufacturing system for Adeno-associated virus...
Clinical Trials
Bharat Biotech to collaborate with Washington University School of Medicine on COVID-19 nasal vaccine
Vaccine maker Bharat Biotech has entered into an agreement with Washington University School of Medicine in St. Louis as part of which it will...
Clinical Trials
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen’s COVID-19 Vaccine Candidate
Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by...
Clinical Trials
I-Mab receives China NMPA clearance to begin phase 1 trial of lemzoparlimab in relapsed/refractory advanced lymphoma
I-Mab, a clinical stage biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has cleared...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read
